Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype

Abstract

Background and aimsSystemic low-grade inflammation, measured by plasma high-sensitivity C-reactive protein (hsCRP) levels, is an important risk factor for atherosclerotic cardiovascular disease (ASCVD). To date, however, it is unknown whether plasma hsCRP is associated with adverse histological plaque features. MethodsPlaques were derived during carotid endarterectomy. Patients with hsCRP levels ≥2 mg/L were evaluated for pro-inflammatory and adverse plaque characteristics, as well as future ASCVD events, and compared with patients with low hsCRP levels. Logistic and linear regression analyses in addition to subdistribution hazard ratios were conducted, adjusted for cardiovascular risk factors. ResultsA total of 1,096 patients were included, of which 494 (46.2%) had hsCRP levels of ≥2 mg/L. Elevated hsCRP levels of ≥2 mg/L were independently associated with levels of plaque interleukin 6, beta coefficient of 109.8 (95% confidence interval (CI): 33.4, 186.5; p=0.005) pg/L, interleukin 8 levels, 194.8 (110.4, 378.2; p=0.03) pg/L and adiponectin plaque levels, -16.8 (-30.1, -3.6; p=0.01) μg/L, compared with plaques from patients with low hsCRP levels. Histological analysis revealed increased vessel density in high hsCRP patients, odds ratio (OR) of 1.57 (1.20, 2.09; p=0.001), larger lipid core, 1.35 (1.02, 1.73; p=0.04), and increased macrophage content, 1.32 (1.02, 1.73; p=0.04). Over a 3-year follow-up period, hsCRP levels ≥2 mg/L were associated with a hazard ratio of 1.81 (1.03, 3.16; p=0.04) for coronary artery disease event risk. ConclusionsThe distinct inflammatory and histological features observed in carotid plaques among individuals with hsCRP levels ≥2 mg/L underscore the utility of plasma hsCRP as a potent identifier for patients harboring high-risk plaques.